Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Rheumatic Diseases D012216 7 associated lipids
Rhinitis D012220 10 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Osteosarcoma D012516 50 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Seizures D012640 87 associated lipids
Shock D012769 11 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Shock, Septic D012772 11 associated lipids
Shock, Traumatic D012774 4 associated lipids
Sneezing D012912 6 associated lipids
Spasm D013035 5 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Stomach Ulcer D013276 75 associated lipids
Stomatitis D013280 14 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Tangier Disease D013631 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Arnoux B et al. Effect of PAF-acether in non-human primates. 1988 Prog. Clin. Biol. Res. pmid:2837781
Hecker G et al. Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206. 1987 Prog. Clin. Biol. Res. pmid:2444988
Stewart AG and Piper PJ Actions of platelet-activating factor in the coronary circulation of the guinea pig in vitro. 1987 Prog. Clin. Biol. Res. pmid:3671383
Stjernschantz J and Bito LZ The ocular effects of eicosanoids and other autacoids: historic background and the need for a broader perspective. 1989 Prog. Clin. Biol. Res. pmid:2571999
Valone FH et al. Mechanisms for biphasic or persistent immunologic reactions induced by platelet-activating factor. 1989 Prog. Clin. Biol. Res. pmid:2685826
Piper PJ and Yaacob HB Interactions of platelet activating factor, thromboxane A2 and leukotrienes in guinea-pig heart. 1989 Prog. Clin. Biol. Res. pmid:2508116
Gasser H et al. Effect of platelet-activating factor (PAF) administration in chronically instrumented sheep--analysis of PAF in plasma. 1989 Prog. Clin. Biol. Res. pmid:2780708
Bonavida B et al. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock. 1989 Prog. Clin. Biol. Res. pmid:2780710
Heuer H Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity. 1989 Prog. Clin. Biol. Res. pmid:2780739
Bahrami S et al. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments. 1989 Prog. Clin. Biol. Res. pmid:2780740
Camussi G et al. Anti-inflammatory peptides inhibit synthesis of platelet-activating factor. 1990 Prog. Clin. Biol. Res. pmid:2204939
Bahr T et al. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models. 1989 Prog. Clin. Biol. Res. pmid:2798447
Bradley LM et al. The role of lipid mediators in hypoxic pulmonary vasoconstriction in newborns. 1989 Prog. Clin. Biol. Res. pmid:2798449
Baker RC Ethanol modulation of the effects of platelet-activating factor on human platelets and a macrophage cell line. 1990 Prog. Clin. Biol. Res. pmid:2300602
Harper MJ et al. Platelet-activating factor (PAF) and blastocyst-endometrial interactions. 1989 Prog. Clin. Biol. Res. pmid:2542988
Etienne A et al. Possible involvement of platelet-activating factor in endotoxin-induced abortion. 1988 Prog. Clin. Biol. Res. pmid:3393560
McNamara PJ et al. The interaction of alpha-1-acid glycoprotein with endogenous autocoids, in particular, platelet activating factor (PAF). 1989 Prog. Clin. Biol. Res. pmid:2674967
Braquet P and Hosford D The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS). 1989 Prog. Clin. Biol. Res. pmid:2675060
Kelton JG et al. The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura. 1990 Prog. Clin. Biol. Res. pmid:2191308
Mencia-Hurerta JM et al. The role of platelet-activating factor (PAF) in immune and cytotoxic processes. 1989 Prog. Clin. Biol. Res. pmid:2675061
Heuer H and Casals-Stenzel J The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086. 1989 Prog. Clin. Biol. Res. pmid:2675077
Lefer AM Platelet activating factor (PAF) and its role in cardiac injury. 1989 Prog. Clin. Biol. Res. pmid:2678133
Benveniste J Paf-acether, an ether phospho-lipid with biological activity. 1988 Prog. Clin. Biol. Res. pmid:3071808
Dulioust A et al. Immunoregulatory functions of paf-acether (platelet-activating factor). 1988 Prog. Clin. Biol. Res. pmid:3071809
Page CP and Robertson DN The role of PAF in altered airway responsiveness. 1988 Prog. Clin. Biol. Res. pmid:3289016
Schirmer WJ et al. Systemic and renal hemodynamic response to platelet activating factor. 1989 Prog. Clin. Biol. Res. pmid:2726980
Dhainaut JF et al. Platelet-activating factor antagonists as therapeutic strategy in sepsis. 1994 Prog. Clin. Biol. Res. pmid:7831364
Miller CL Infection in massively injured patients. 1982 Prog. Clin. Biol. Res. pmid:6757964
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Valone FH Interrelationships among platelet-activating factor binding and metabolism and induction of platelet activation. 1988 Prog. Clin. Biol. Res. pmid:2850575
Shukla SD and Morrison WJ Platelet activating factor receptor occupancy in relation to activation and desensitization of phosphoinositide specific phospholipase C. 1988 Prog. Clin. Biol. Res. pmid:2850576
Ishii S and Shimizu T Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. 2000 Prog. Lipid Res. pmid:10729607
Whatley RE et al. Lipid metabolism and signal transduction in endothelial cells. 1990 Prog. Lipid Res. pmid:2128404
Itabe H Oxidized phospholipids as a new landmark in atherosclerosis. 1998 Jul-Aug Prog. Lipid Res. pmid:9829125
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Hikiji H et al. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. 2008 Prog. Lipid Res. pmid:18187046
Frenkel RA et al. The biochemical role of platelet-activating factor in reproduction. 1996 Prog. Lipid Res. pmid:8944225
Snyder F et al. The role of transacylases in the metabolism of arachidonate and platelet activating factor. 1992 Prog. Lipid Res. pmid:1641397
Tokumura A A family of phospholipid autacoids: occurrence, metabolism and bioactions. 1995 Prog. Lipid Res. pmid:7480064
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Hanahan DJ and Kumar R Platelet activating factor; chemical and biochemical characteristics. 1987 Prog. Lipid Res. pmid:3313430
Foegh ML et al. Fatty acids and eicosanoids in organ transplantation. 1986 Prog. Lipid Res. pmid:3321095
Touvay C et al. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. 1986 Prog. Lipid Res. pmid:2827186
Damiani E and Ullrich SE Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. 2016 Prog. Lipid Res. pmid:27073146
Grassi S and Pettorossi VE Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. 2001 Prog. Neurobiol. pmid:11311461
Maclennan KM et al. Platelet-activating factor in the CNS. 1996 Prog. Neurobiol. pmid:9015828
Mike I et al. The differences in 12-hydroxyeicosatetraenoic acid and thromboxane B2 release from guinea pig platelets. 1991 Prostaglandins pmid:1763200
Wallace JL and Whittle BJ Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. 1986 Prostaglandins pmid:3726156
Rossi AG and O'Flaherty JT Prostaglandin binding sites in human polymorphonuclear neutrophils. 1989 Prostaglandins pmid:2549574
Montrucchio G et al. In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. 1986 Prostaglandins pmid:3797692
McCulloch RK and Vandongen R Mechanisms of platelet activating factor-induced aggregation and secretion in human platelets. 1990 Prostaglandins pmid:2106712
Silver RK et al. Acetylsalicylic acid inhibits anticardiolipin antibody-induced platelet-activating factor (PAF) synthesis. 1993 Prostaglandins pmid:8430224
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Toyofuku T et al. Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep. 1986 Prostaglandins pmid:3754344
Stratton MD et al. The effect of Clostridium difficile toxin on colonocyte prostanoid activity. 1994 Prostaglandins pmid:7892508
Bussolino F and Camussi G Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation. 1980 Prostaglandins pmid:6258196
Silver RK et al. Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and preterm delivery. 1992 Prostaglandins pmid:1542743
Cucala M et al. Central regulation of gastric acid secretion by platelet-activating factor in anesthesized rats. 1989 Prostaglandins pmid:2499013
Adnot S et al. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. 1986 Prostaglandins pmid:3562865
Levine L Actions of vanadate on arachidonic acid metabolism by cells in culture. 1991 Prostaglandins pmid:2020748
Bourgain RH et al. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall. 1985 Prostaglandins pmid:3931178
Boughton-Smith NK et al. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. 1989 Prostaglandins pmid:2506613
Levine L Effects of okadaic acid on agonist-stimulated PGI2 production by rat liver cells (the C-9 cell line). 1991 Prostaglandins pmid:1647047
Dembinska-Kiec A et al. The effects of platelet-activating factor on flow rate and eicosanoid release in the isolated perfused rat gastric vascular bed. 1989 Prostaglandins pmid:2717778
Kaminski DL et al. Studies on the etiology of acute acalculous cholecystitis: the effect of lipopolysaccharide on human gallbladder mucosal cells. 1994 Prostaglandins pmid:8041874
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Kim CJ et al. Eosinophils recruited to the lung by segmental antigen challenge show a reduced chemotactic response to leukotriene B4. 1994 Prostaglandins pmid:8066187
Goldenberg MM and Meurer RD A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat. 1984 Prostaglandins pmid:6505225
Whatley RE et al. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. 1992 Prostaglandins pmid:1546171
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Jager GV et al. Antagonist of platelet-activating factor prevents prostaglandin E2 induced ocular hypertension in rabbits. 1993 Prostaglandins pmid:8424134
Radeau T et al. Enhanced esterification process of 5-hydroxyeicosatetraenoic acid (5-HETE) in PMN from asthmatic patients. 1992 Prostaglandins pmid:1410523
Orevi M et al. A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. 1992 Prostaglandins pmid:1584997
Qu X et al. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. 1996 Prostaglandins pmid:8935185
Yue TL et al. Pharmacologic profile of BN 50739, a new PAF antagonist in vitro and in vivo. 1990 Prostaglandins pmid:2353116
Cirino M et al. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. 1986 Prostaglandins pmid:3763941
Wallace JL and Whittle BJ Profile of gastrointestinal damage induced by platelet-activating factor. 1986 Prostaglandins pmid:3763942
Bourgain RH et al. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig. 1986 Prostaglandins pmid:3763943
Guinot P et al. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. 1986 Prostaglandins pmid:3763944
Jancar S et al. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. 1988 Prostaglandins pmid:2969600
Pignol B et al. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes. 1987 Prostaglandins pmid:3313526
Braquet P and Rola-Pleszczynski M The role of PAF in immunological responses: a review. 1987 Prostaglandins pmid:3313527
Young JM et al. Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse. 1985 Prostaglandins pmid:4081060
Is there a case for PAF-acether antagonists? Institut Pasteur, Paris, 21 June 1985. Abstracts. 1985 Prostaglandins pmid:4081064
Slama H et al. Metabolism of arachidonic acid by caruncular and allantochorionic tissues in cows with retained fetal membranes (RFM). 1993 Prostaglandins pmid:8380936
Turner-Gomes SO et al. Effect of ambient oxygen changes on platelet activating factor production by fetal ovine endothelial cells. 1991 Prostaglandins pmid:1862226
Ashida Y et al. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. 1989 Prostaglandins pmid:2748922
Myers SI et al. Platelet activating factor (PAF) stimulates release of PGI2 from inflamed rabbit gallbladder cell cultures. 1995 Prostaglandins pmid:8588069
Spinnewyn B et al. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. 1987 Prostaglandins pmid:3432553
Armstrong RA et al. Mechanism of the inhibition of platelet aggregation produced by prostaglandin F2 alpha. 1985 Prostaglandins pmid:2988022
Archer CB et al. Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. 1984 Prostaglandins pmid:6203139
Kioumis I et al. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man. 1988 Prostaglandins pmid:3237997
Sirois MG et al. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240. 1988 Prostaglandins pmid:3238010
Voelkel NF et al. PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung. 1986 Prostaglandins pmid:3024235
Braquet M et al. Leukocytic functions in burn-injured patients. 1985 Prostaglandins pmid:2989978
Bonnet J et al. Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. 1983 Prostaglandins pmid:6419289
Fernandes AJ et al. Mechanisms of thrombocytopenia in the acute phase of antigen-induced arthritis in rabbits. 1991 Prostaglandins pmid:1801060
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520